Université Laval University was the first French-language University to be founded in America. Originating from the Séminaire de Québec, which was founded in 1663 by Bishop François de Montmorency-Laval, it was officially founded in 1852. The University grew so much that in 1925 it left the walls of Old Québec, and from 1950 all the pavilions were grouped on the Sainte-Foy campus. The 1960’s and 70’s were marked by a boom in research: the first research centers opened their doors (Nordic studies, endocrinology, oceanography ...), laboratories multiplied and the role of professor-researcher was affirmed. Today, Université Laval ranks among the top ten in the country for its research activities in terms of the funds it obtains. Université Laval has been a partner of the CERVO Center since its creation in 1987. Its support and contribution have been essential to the development of the Center.
The Centre intégré universitaire de santé et de services sociaux de la Capitale Nationale (CIUSSS-CN) contributes to the improvement of the overall health of the population in its territory. It provides users and their loved ones with local, integrated and accessible health care and social services. Focused on quality, safety and performance, these care and services are based on best practices and innovation, with the participation of users, their families and those working within the organization. Affiliated with Université Laval and in collaboration with educational institutions, it provides quality education, develops knowledge and advanced practices. It also promotes the sharing and dissemination of scientific and clinical knowledge. The CIUSSS-CN brings together four research centers and four university institutes.
The CERVO foundation aims to provide people affected by a neurological disease, a mental illness or an addiction hope of healing, by funding discovery and innovation to better understand the brain, while contributing to initiatives that are promising in terms of care and education in Eastern Quebec. It aims to attract and retain in Quebec City world-class talents working in neuroscience research. To this end, it contributes to providing researchers with a modern, high-quality, reputable research environment that is known to facilitate and stimulate the advancement of research.
To support mental health and the addiction recovery process, the CERVO Foundation supports services, care and support as well as initiatives that impact the ability of individuals to rebuild their lives, and to participate in society as full citizens. The CERVO Foundation wishes to help disseminate and demystify knowledge about the brain to patients, their families and stakeholders and to provide them with tools to support them in understanding, intervening and monitoring brain diseases and addiction.
The collaborations of CERVO center researchers at the national level are very numerous. One of the most recent is the Canadian Neurophotonics Platform - a technology platform for developing and maximizing the exploitation of photonic technologies, bringing together researchers from seven Canadian universities: University of British Columbia, University of Calgary, University of Alberta, University of Ottawa, McGill University, Université Laval and Dalhousie University.
The CERVO Centre is also at the origin of the Quebec Pain Research Network (QPRN, qprn.ca) which federates the efforts of Quebec research on chronic pain. The QPRN is an excellent example of private-public partnership success in the service of research and improvement of care (more than $ 10 million in partnership).
Jean-Pierre Julien is Team Leader for a Brain Canada Group Grant titled "Preclinical and Clinical Studies on Withanolides: Therapeutic Effects, Molecular Signatures and Biomarkers", obtained through a partnership with the Canadian ALS Society.
Collaborators and international meetings
The CERVO Centre participates in many international collaborations. A partnership with the Université de Bordeaux has led to the establishment of the International Frontiers in Neurophotonics Symposium, which is held every two years, alternating between Québec city and Bordeaux (https://frontiersneurophotonics.org).
Other partnerships have been established recently with the group of the Center for Nanoscale Biophotonics (CNBP) in Australia http://cnbp.org.au/, and the new 'Neurophotonics Center' at Boston University http://www.bu.edu/neurophotonics-nrt/ , and with the Center for Biophotonics at UC Davis in California http://www.cbst.ucdavis.edu/.
The CERVO Center is also part of the European Neurasmus network, with Université Laval being one of the five partner Universities (http: // www.neurasmus.u-bordeaux2.fr/about-neurasmus-network.html).
The Neurophotonics Center also organizes the International Frontiers of Neurophotonics Summer School every year since 2007 (https://neurophotonics.ca/frontiers-in -neurophotonics-summer-school) This school attracts applications for registration from all around the world. It represents interdisciplinary training of the highest quality. The organisation of this event requires very important physical resources, but also human resources, as the teachers work closely with the students until very late at night for about ten days. The school has fostered the creation and strengthening of a many collaborations. Professors Jean-Pierre Julien and his team organize an annual International Symposium on Amyotrophic Lateral Sclerosis. The annual André-Delambre Foundation Symposium on Amyotrophic Lateral Sclerosis brings together ALS experts from around the world and alternates between Montreal and Quebec City. It is a recognized international symposium; the 13th edition in 2017 brought together 120 participants and 24 guest speakers from 7 countries. The symposium is funded by the André-Delambre Foundation, ALS Quebec and ALS Canada. Learn more about the symposium here: